Concepedia

David Hurley

DH

15

Publications

743

Citations

12

H-Index

1989

Active since

Affiliations

Endo Pharmaceuticals (United States)(Current)

Cotton (United States)

Merck & Co., Inc., Rahway, NJ, USA (United States)

University of Cincinnati

University of California San Diego

David Hurley is an author at Endo Pharmaceuticals (United States) specializing in medicine, pediatrics, and civic engagement.

ORCID

Top concepts

Publications per year

1989–2022

15

Publications

15

Immunogenicity and Safety of 13-Valent Pneumococcal Conjugate Vaccine in Infants and Toddlers

Sylvia H. Yeh, Alejandra Gurtman, David Hurley et al. · PEDIATRICS · 2010 · 234 citations

Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV15) in healthy infants

David Greenberg, Patricia Hoover, Timo Vesikari et al. · Vaccine · 2018 · 107 citations

, , +9

Social Behavior in Public Space: An Analysis of Behavioral Adaptations to CCTV

Lorraine Mazerolle, David Hurley, Mitchell B. Chamlin · Security Journal · 2002 · 80 citations

, , +7

A Phase II Trial of Safety, Tolerability and Immunogenicity of V114, a 15-Valent Pneumococcal Conjugate Vaccine, Compared With 13-Valent Pneumococcal Conjugate Vaccine in Healthy Infants

Heather Platt, David Greenberg, Bruce Tapiéro et al. · The Pediatric Infectious Disease Journal · 2020 · 63 citations · Full text

A dose ranging study of 2 different formulations of 15-valent pneumococcal conjugate vaccine (PCV15) in healthy infants

Randall G. Rupp, David Hurley, Staci Grayson et al. · Human Vaccines & Immunotherapeutics · 2019 · 60 citations · Full text

Rows per page

1–5 of 15